10,563 Shares in HCA Healthcare, Inc. $HCA Bought by B. Metzler seel. Sohn & Co. AG

Key Points

• B. Metzler seel. Sohn & Co. AG acquired 10,563 shares of HCA Healthcare during the second quarter, valued at approximately $4.1 million. Institutional investors now own 62.73% of the company.
• HCA Healthcare reported quarterly earnings of $7.59 per share, exceeding estimates, while revenue rose 8.7% year over year to $20.23 billion. The company also declared a quarterly dividend of $0.78 per share, for an annualized yield of about 0.7%.
• Analysts maintain a consensus “Moderate Buy” rating with an average price target of $462.64, although several firms recently lowered their targets. HCA shares opened at $429.08, below their 52-week high of $556.52.

B. Metzler seel. Sohn & Co. AG bought a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 10,563 shares of the company's stock, valued at approximately $4,118,000.

Other hedge funds also recently bought and sold shares of the company. Palisade Asset Management LLC bought a new position in HCA Healthcare in the third quarter worth $26,000. Ares Financial Consulting LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $31,000. Cedar Mountain Advisors LLC acquired a new position in HCA Healthcare in the first quarter valued at approximately $33,000. MCF Advisors LLC increased its holdings in HCA Healthcare by 213.0% in the fourth quarter. MCF Advisors LLC now owns 72 shares of the company's stock valued at $34,000 after purchasing an additional 49 shares during the last quarter. Finally, MidFirst Bank acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $28,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Price Performance

NYSE:HCA opened at $429.08 on Friday. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52. The company has a market cap of $92.90 billion, a P/E ratio of 14.36, a P/E/G ratio of 1.41 and a beta of 1.10. The stock's fifty day moving average price is $397.16 and its two-hundred day moving average price is $444.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion for the quarter, compared to analysts' expectations of $19.76 billion. During the same quarter in the previous year, the company earned $6.84 earnings per share. HCA Healthcare's quarterly revenue was up 8.7% on a year-over-year basis. On average, analysts expect that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's payout ratio is currently 10.45%.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Cantor Fitzgerald lowered their target price on HCA Healthcare from $588.00 to $525.00 and set an "overweight" rating for the company in a research note on Tuesday, July 7th. Truist Financial reduced their target price on shares of HCA Healthcare from $535.00 to $495.00 and set a "buy" rating for the company in a research note on Monday, July 27th. JPMorgan Chase & Co. cut their price target on HCA Healthcare from $490.00 to $425.00 and set a "neutral" rating on the stock in a report on Thursday. Sanford C. Bernstein reiterated a "market perform" rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Finally, Wall Street Zen cut shares of HCA Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday, May 2nd. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, HCA Healthcare has an average rating of "Moderate Buy" and a consensus price target of $462.64.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source